Mallinckrodt


Mallinckrodt develops, manufactures, markets and distributes innovative treatments for underserved patient populations within neurology, rheumatology, nephrology, pulmonology, and ophthalmology.

Industries

Headquarters

Dublin, Ireland

Employees

1,001-5,000

Links


Org chart

Sigurdur Olafsson
President & CEO
Collapse
Bryan Reasons
Executive Vice President and Chief Financial Officer
Jason Goodson
EVP & Chief Strategy Officer
Mark Tyndall
EVP & Chief Legal Officer & Corporate Secretary
Stephen Welch
EVP & Head of Specialty Generics
Lori L Hamilton
Senior Executive Assistant To President And Ceo, Mark Trudeau
Marianna Boyd
General Manager, Canada
Steve Hawthorne
Vice President Of Manufacturing
Paul Coiante
Vice President Of Sales North America
Anthony Lassiter
VP Global Pharmacovigilance And Medical Information
Jacqueline Delfgaauw
Vp, Head Of Research & Development Strategic Operations
Jae Han Park
Vice President / Head Of Specialty Generics R&d

Board & advisors

Jon Zinman
Director
Wes Wheeler
Director


Offices